These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10430451)

  • 1. The Mayo Clinic-Canadian cooperative trial of sulfasalazine in active multiple sclerosis.
    Paty DW
    Neurology; 1999 Jul; 53(2):437. PubMed ID: 10430451
    [No Abstract]   [Full Text] [Related]  

  • 2. The Mayo Clinic-Canadian Cooperative trial of sulfasalazine in active multiple sclerosis.
    Noseworthy JH; O'Brien P; Erickson BJ; Lee D; Sneve D; Ebers GC; Rice GP; Auty A; Hader WJ; Kirk A; Duquette P; Carter J; Francis G; Metz L; Shuster E
    Neurology; 1998 Nov; 51(5):1342-52. PubMed ID: 9818858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are clinical trials of therapeutic agents for MS long enough?
    Rudge P
    Lancet; 1999 Mar; 353(9158):1033-4. PubMed ID: 10199348
    [No Abstract]   [Full Text] [Related]  

  • 4. Two in one against motor neuron degeneration: tackling oxidative stress and inflammation with a sulfasalazine derivative.
    Clement AM
    J Neurochem; 2012 Sep; 122(5):869-71. PubMed ID: 22730915
    [No Abstract]   [Full Text] [Related]  

  • 5. Symptomatic and disease-modifying therapies for multiple sclerosis: recent developments: highlights of the 9th Annual Meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis, October 3, 2004, Toronto, Ontario, Canada.
    Cook SD
    Rev Neurol Dis; 2005; 2(1):23-6. PubMed ID: 16400300
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of sulfasalazine in the treatment of generalized lichen planus: randomized double-blinded clinical trial on 52 patients.
    Omidian M; Ayoobi A; Mapar MA; Feily A; Cheraghian B
    J Eur Acad Dermatol Venereol; 2010 Sep; 24(9):1051-4. PubMed ID: 20158586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminosalicylates for induction of remission or response in Crohn's disease.
    Lim WC; Hanauer S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008870. PubMed ID: 21154400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [5-ASA versus sulfasalazine].
    Varela E
    Acta Gastroenterol Latinoam; 1994; 25(5):317-9. PubMed ID: 7785405
    [No Abstract]   [Full Text] [Related]  

  • 9. Is there a role for sulfasalazine in the treatment of alopecia areata?
    Bakar O; Gurbuz O
    J Am Acad Dermatol; 2007 Oct; 57(4):703-6. PubMed ID: 17610992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of alopecia areata with sulfasalazine.
    Misery L; Sannier K; Chastaing M; Le Gallic G
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):547-8. PubMed ID: 17373991
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical images: healing of sacroiliitis with leflunomide and sulfasalazine treatment.
    Li SG
    Arthritis Rheum; 2008 May; 58(5):1527. PubMed ID: 18438815
    [No Abstract]   [Full Text] [Related]  

  • 12. [The treatment of rheumatoid polyarthritis using salazosulfapyridine (Salazopyrine). A 6-month open study of 34 patients].
    Ghozlan R; Dupuis M; Schwak A; Jorro P; Lecarpentier C; Guillon C
    Rev Rhum Mal Osteoartic; 1988 Feb; 55(2):127-30. PubMed ID: 2895959
    [No Abstract]   [Full Text] [Related]  

  • 13. Mesalamine may be preferable to sulfasalazine in dermatologic therapeutics.
    Burkhart CG
    Int J Dermatol; 2006 Jun; 45(6):779-80; author reply 780. PubMed ID: 16796652
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunosuppressants and multiple sclerosis].
    Ruiz-Peña JL; Izquierdo-Ayuso G
    Rev Neurol; 2002 Aug 16-31; 35(4):373-80. PubMed ID: 12235571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of anaphylaxis by sulfasalazine in rats.
    Lee EH; Kim HM
    Pharmacology; 1998 May; 56(5):223-9. PubMed ID: 9597688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic rhinosinusitis: potential new use for topical sulfasalazine.
    Karr RM
    J Allergy Clin Immunol Pract; 2014; 2(3):349-50.e1. PubMed ID: 24811030
    [No Abstract]   [Full Text] [Related]  

  • 17. A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies.
    Burgos-Vargas R; Vázquez-Mellado J; Pacheco-Tena C; Hernández-Garduño A; Goycochea-Robles MV
    Ann Rheum Dis; 2002 Oct; 61(10):941-2. PubMed ID: 12228171
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chronic polyarthritis].
    MMW Fortschr Med; 2001 May; 143(21):59-60. PubMed ID: 11420837
    [No Abstract]   [Full Text] [Related]  

  • 19. Long term outcome of treatment with sulphasalazine in rheumatoid arthritis.
    Situnayake RD; McConkey B
    Drugs; 1986; 32 Suppl 1():71-2. PubMed ID: 2877857
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure of sulfasalazine to influence experimental autoimmune encephalomyelitis.
    Uitdehaag BM; Polman CH; de Groot CJ; Huitinga I; Dijkstra CD
    Acta Neurol Scand; 1991 Aug; 84(2):173-4. PubMed ID: 1683088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.